Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates estradiol mitigates endothelial cuproptosis via the SP1/ATP7B axis in cell and mouse models, highlighting a potential target for sepsis.
Sepsis-associated endothelial injury is a central event driving microcirculatory dysfunction and multiple organ failure; however, effective targeted therapies are lacking. The role of cuproptosis, a recently identified form of programmed cell death, in sepsis-induced endothelial dysfunction has not yet been clearly defined, and this limits the advancement of associated therapeutic approaches. In vitro, human umbilical vein endothelial cells (HUVECs) were exposed to lipopolysaccharide (LPS) to induce endothelial cell injury. The cells were then treated with estradiol (E2) to investigate the protective effects of E2 on cuproptosis-associated alterations in LPS-treated HUVECs. In vivo, endotoxemic mice were treated with E2, and the effects on cytokine levels, survival rate, organ injury, and cuproptosis-related markers were evaluated. The regulatory relationship between SP1 and ATP7B was examined using bioinformatic prediction, loss- and gain-of-function experiments, dual-luciferase reporter assays, and ChIP-PCR. LPS induced endothelial cell injury accompanied by cuproptosis-associated alterations, as evidenced by downregulation of ATP7B, FDX1, LIAS, and PDHB expression and upregulation of HSP70 expression. These changes were accompanied by mitochondrial depolarization, intracellular accumulation of copper, and depletion of glutathione (GSH) and ATP. Copper loading and chelation experiments further supported the involvement of a copper-dependent process. Treatment with E2 partially reversed these alterations and restored ATP7B expression. Predictive bioinformatics and molecular assays demonstrated that SP1 binds to the ATP7B promoter and negatively regulates transcription of the ATP7B gene. E2 inhibited LPS-induced SP1 upregulation, and SP1 knockdown increased ATP7B levels and alleviated endothelial injury and cuproptosis-associated alterations, whereas SP1 overexpression substantially reversed the protective effects of E2. In vivo experiments revealed that E2 treatment of endotoxemic mice significantly improved survival, attenuated multiple organ injury, and ameliorated altered copper homeostasis and cuproptosis-associated molecular changes. Early E2 post-treatment also reversed SP1/ATP7B alterations and reduced elevated copper levels. These findings support the involvement of a copper-dependent, cuproptosis-associated process in endothelial damage induced by LPS and suggest that E2 exerts protective effects on the endothelium at least in part through regulation of the SP1/ATP7B axis and copper homeostasis. The SP1/ATP7B pathway may therefore represent a potential molecular target for further investigation in sepsis-associated endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: